Travelzoo
NASDAQ:TZOOAdvertising Agencies
+$0.32 today
- Market cap
- $52.13M
- Beta
- 1.30
- P/E (TTM)
- 29.5
- EPS (TTM)
- $0.37
Volume 0.05M
Average 0.20M
TZOO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
TravelzooNASDAQ: TZOO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development grows in line with its trailing trend
Q1 FY2026 research & development of $664K rose 4.7% year over year, in line with the +4.3% change in trailing-twelve-month research & development. Sequentially, it rose 12.9% from the prior quarter. Over 3 fiscal years it compounded at +7.3% a year.
Context
- Research & development amounted to 2.8% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +4.7% holds above the trailing-twelve-month pace of +4.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 2.55M USD
- Year-over-year change
- +6.0%
- 4-year CAGR
- -0.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.55M | +6.0% |
| FY2024 | 2024-12-31 | 2.41M | +13.9% |
| FY2023 | 2023-12-31 | 2.11M | +2.4% |
| FY2022 | 2022-12-31 | 2.06M | -20.3% |
| FY2021 | 2021-12-31 | 2.59M | — |
Research & Development vs competitors
How TZOO compares with its peers on the latest reported figures
- TZOO's LTM Mar 2026 research & development of $2.58M is the 4th highest of the 8 companies compared; the peer median is $0.
- Its year-over-year change of +4.3% is the highest of 4, against a peer median of -19.9%.
- Research & development amounts to 2.8% of revenue for TZOO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $59.58M | -18.0% | — | 12.7% | |
| LTM Mar 2026 | $9.48M | -19.9% | -12.1% | 21.2% | |
| LTM Mar 2026 | $5.01M | — | -30.6% | 22.9% | |
| LTM Mar 2026 | $2.58M | +4.3% | +7.3% | 2.8% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TZOO) | $0 | -19.9% | -21.4% | 0.0% | |
Competitors are the stored peer set for TZOO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 62.71M | 70.6M | 84.48M | 83.9M | 91.72M |
| Cost of Revenue | 11.39M | 10M | 10.93M | 10.47M | 18.08M |
| Gross Profit | 51.32M | 60.6M | 73.54M | 73.43M | 73.64M |
| Gross Margin | 81.8% | 85.8% | 87.1% | 87.5% | 80.3% |
| Research & Development | 2.59M | 2.06M | 2.11M | 2.41M | 2.55M |
| Selling, General & Admin | 50.05M | 50.98M | 55.86M | 52.53M | 64.19M |
| Operating Expenses | 52.64M | 53.04M | 57.97M | 54.94M | 66.74M |
| Depreciation & Amortization | 1.82M | 2.19M | 1.89M | 907K | 303K |
| EBITDA | 4.51M | 12.15M | 19.01M | 19.99M | 7.96M |
| EBITDA Margin | 7.2% | 17.2% | 22.5% | 23.8% | 8.7% |
| Operating Income | (1.31M) | 7.56M | 15.57M | 18.5M | 6.91M |
| Operating Margin | -2.1% | 10.7% | 18.4% | 22.0% | 7.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 4.01M | 2.4M | 1.54M | 588K | 753K |
| Income Before Tax | 2.69M | 9.96M | 17.11M | 19.09M | 7.66M |
| Pre-Tax Margin | 4.3% | 14.1% | 20.3% | 22.7% | 8.4% |
| Income Tax Expense | 1.78M | 3.27M | 5.11M | 5.4M | 2.68M |
| Net Income | 911K | 6.63M | 12.37M | 13.56M | 4.7M |
| Net Margin | 1.5% | 9.4% | 14.6% | 16.2% | 5.1% |
| EPS (Basic) | 0.08 | 0.54 | 0.83 | 1.08 | 0.42 |
| EPS (Diluted) | 0.07 | 0.53 | 0.83 | 1.06 | 0.41 |
| Weighted Avg Shares | 11.65M | 12.37M | 14.9M | 12.59M | 11.18M |
| Weighted Avg Shares (Diluted) | 12.99M | 12.56M | 14.96M | 12.85M | 11.48M |
Travelzoo
NASDAQ:TZOO
Intrinsic Alpha fair value
Locked
Current Price
$5.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.